Patents by Inventor Yuko Yamamoto

Yuko Yamamoto has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10245842
    Abstract: A printer has a print unit that prints bidirectionally on a print medium; and an adjustment unit that prints, by the print unit, in contrast with each other on a second print medium, a first direction print image generated using first direction color conversion information for a first print medium, and a second direction print image generated using second direction color conversion information for a second print medium; the second direction color conversion information for the second print medium being second direction color conversion information for the first print medium that was adjusted.
    Type: Grant
    Filed: February 19, 2016
    Date of Patent: April 2, 2019
    Assignee: Seiko Epson Corporation
    Inventors: Takumi Shimomukai, Yuko Yamamoto
  • Patent number: 10221195
    Abstract: The present invention relates to a compound or a pharmacologically acceptable salt thereof having excellent tissue non-specific alkaline phosphatase inhibitory activity. The present invention provides a compound represented by the formula (I): wherein R1 represents a hydrogen atom, an optionally substituted C1-6 alkyl group, or the like, R2 and R3 are the same or different and each represent a hydrogen atom, an optionally substituted C1-6 alkyl group, or the like, R4 and R5 are the same or different and each represent a hydrogen atom, an optionally substituted C1-6 alkyl group, or the like, R6 represents a hydrogen atom or the like, each R7 may be the same or different and may each represent an optionally substituted C1-6 alkoxy group or the like, X represents —CH?, —C(—R7)?, or —N?, and m represents 1 to 4, or a pharmacologically acceptable salt thereof.
    Type: Grant
    Filed: January 18, 2018
    Date of Patent: March 5, 2019
    Assignees: Daiichi Sankyo Company, Limited, Sanford Burnham Prebys Medical Discovery Institute
    Inventors: Shojiro Miyazaki, Yuko Yamamoto, Keisuke Suzuki, Masaharu Inui, Masanori Izumi, Kaori Soma, Anthony Pinkerton, Taeko Shinozaki
  • Publication number: 20180259463
    Abstract: In respective methods for manufacturing a high aspect ratio structure and an ultrasonic probe, a plurality of holes extending in a direction crossing a main surface of a substrate are formed, a plurality of first regions and second regions excluding the first regions from the main surface are periodically defined, and partition walls between the plurality of holes formed in the substrate corresponding to the first regions are removed by etching so that part of each of the partition walls within a predetermined range excluding a bottom portion is left. A high aspect ratio structure and an X-ray imaging apparatus include, over a side wall, a porous member including a plurality of holes extending in a direction crossing a grating surface within a predetermined range excluding a bottom portion in each of a plurality of recesses in a grating.
    Type: Application
    Filed: February 28, 2018
    Publication date: September 13, 2018
    Inventors: Mitsuru YOKOYAMA, Yuko Yamamoto
  • Publication number: 20180141960
    Abstract: The present invention relates to a compound or a pharmacologically acceptable salt thereof having excellent tissue non-specific alkaline phosphatase inhibitory activity. The present invention provides a compound represented by the formula (I): wherein R1 represents a hydrogen atom, an optionally substituted C1-6 alkyl group, or the like, R2 and R3 are the same or different and each represent a hydrogen atom, an optionally substituted C1-6 alkyl group, or the like, R4 and R5 are the same or different and each represent a hydrogen atom, an optionally substituted C1-6 alkyl group, or the like, R6 represents a hydrogen atom or the like, each R7 may be the same or different and may each represent an optionally substituted C1-6 alkoxy group or the like, X represents —CH?, —C(—R7)?, or —N?, and m represents 1 to 4, or a pharmacologically acceptable salt thereof.
    Type: Application
    Filed: January 18, 2018
    Publication date: May 24, 2018
    Applicants: Daiichi Sankyo Company, Limited, Sanford Burnham Prebys Medical Discovery Institute
    Inventors: Shojiro Miyazaki, Yuko Yamamoto, Keisuke Suzuki, Masaharu Inui, Masanori Izumi, Kaori Soma, Anthony Pinkerton, Taeko Shinozaki
  • Publication number: 20180111385
    Abstract: A printer has a print unit that prints bidirectionally on a print medium; and an adjustment unit that prints, by the print unit, in contrast with each other on a second print medium, a first direction print image generated using first direction color conversion information for a first print medium, and a second direction print image generated using second direction color conversion information for a second print medium; the second direction color conversion information for the second print medium being second direction color conversion information for the first print medium that was adjusted.
    Type: Application
    Filed: February 19, 2016
    Publication date: April 26, 2018
    Inventors: Takumi SHIMOMUKAI, Yuko YAMAMOTO
  • Patent number: 9920068
    Abstract: The present invention relates to a compound or a pharmacologically acceptable salt thereof having excellent tissue non-specific alkaline phosphatase inhibitory activity. The present invention provides a compound represented by the formula (I): wherein R1 represents a hydrogen atom, an optionally substituted C1-6 alkyl group, or the like, R2 and R3 are the same or different and each represent a hydrogen atom, an optionally substituted C1-6 alkyl group, or the like, R4 and R5 are the same or different and each represent a hydrogen atom, an optionally substituted C1-6 alkyl group, or the like, R6 represents a hydrogen atom or the like, each R7 may be the same or different and may each represent an optionally substituted C1-6 alkoxy group or the like, X represents —CH?, —C(—R7)?, or —N?, and m represents 1 to 4, or a pharmacologically acceptable salt thereof.
    Type: Grant
    Filed: July 7, 2016
    Date of Patent: March 20, 2018
    Assignees: Daiichi Sankyo Company, Limited, Sanford Burnham Prebys Medical Discovery Institute
    Inventors: Shojiro Miyazaki, Yuko Yamamoto, Keisuke Suzuki, Masaharu Inui, Masanori Izumi, Kaori Soma, Anthony Pinkerton, Taeko Shinozaki
  • Publication number: 20180055931
    Abstract: The present invention is a method for controlling a regeneration speed of an animal cell that includes a step of grasping tide-generating force and a step of giving a physical or chemical stimulus to the animal cell according to the magnitude of variation in the tide-generating force.
    Type: Application
    Filed: July 27, 2017
    Publication date: March 1, 2018
    Applicant: TOYOTA BOSHOKU KABUSHIKI KAISHA
    Inventors: Yuko YAMAMOTO, Mao MORIMOTO
  • Publication number: 20180041663
    Abstract: An ink amount upper limit setting apparatus includes a target color designating section that accepts the designation of at least one target color for which an ink amount upper limit is to be set. A patch controller causes an output device to form patches in accordance with output values. A colorimetric value acquiring section acquires colorimetric values of the formed patches. A color reproduction determination output section outputs color reproduction determination information that indicates whether the target color is contained in a color reproduction region for each of ink amount upper limit candidates, on the basis of a coordinate value of the target color and the colorimetric values.
    Type: Application
    Filed: July 27, 2017
    Publication date: February 8, 2018
    Inventor: Yuko YAMAMOTO
  • Patent number: 9879032
    Abstract: The present invention relates to a compound or a pharmacologically acceptable salt thereof having excellent tissue non-specific alkaline phosphatase inhibitory activity. The present invention provides a compound represented by the formula (I): wherein R1 represents a hydrogen atom, an optionally substituted C1-6 alkyl group, or the like, R2 and R3 are the same or different and each represent a hydrogen atom, an optionally substituted C1-6 alkyl group, or the like, R4 and R5 are the same or different and each represent a hydrogen atom, an optionally substituted C1-6 alkyl group, or the like, R6 represents a hydrogen atom or the like, each R7 may be the same or different and may each represent an optionally substituted C1-6 alkoxy group or the like, X represents —CH?, —C(—R7)?, or —N?, and m represents 1 to 4, or a pharmacologically acceptable salt thereof.
    Type: Grant
    Filed: April 6, 2017
    Date of Patent: January 30, 2018
    Assignees: Daiichi Sankyo Company, Limited, Sandford Burnham Prebys Medical Discovery Institute
    Inventors: Shojiro Miyazaki, Yuko Yamamoto, Keisuke Suzuki, Masaharu Inui, Masanori Izumi, Kaori Soma, Anthony Pinkerton, Taeko Shinozaki
  • Patent number: 9751887
    Abstract: The present invention is intended to provide a compound or a pharmacologically acceptable salt thereof which is useful in the treatment of a tumor through its ROS1 kinase enzyme activity inhibitory effect and NTRK kinase enzyme inhibitory effect. The present invention provides a compound having an imidazo[1,2-b]pyridazine structure represented by the general formula (I) or a pharmacologically acceptable salt thereof, and a pharmaceutical composition comprising the compound. In the formula, R1, G, T, Y1, Y2, Y3, and Y4 are as defined herein.
    Type: Grant
    Filed: October 29, 2015
    Date of Patent: September 5, 2017
    Assignee: Daiichi Sankyo Company, Limited
    Inventors: Yasuyuki Takeda, Kenji Yoshikawa, Yoshiko Kagoshima, Yuko Yamamoto, Ryoichi Tanaka, Yuichi Tominaga, Masaki Kiga, Yoshito Hamada
  • Publication number: 20170240562
    Abstract: The present invention relates to a compound or a pharmacologically acceptable salt thereof having excellent tissue non-specific alkaline phosphatase inhibitory activity. The present invention provides a compound represented by the formula (I): wherein R1 represents a hydrogen atom, an optionally substituted C1-6 alkyl group, or the like, R2 and R3 are the same or different and each represent a hydrogen atom, an optionally substituted C1-6 alkyl group, or the like, R4 and R5 are the same or different and each represent a hydrogen atom, an optionally substituted C1-6 alkyl group, or the like, R6 represents a hydrogen atom or the like, each R7 may be the same or different and may each represent an optionally substituted C1-6 alkoxy group or the like, X represents —CH?, —C(—R7)?, or —N?, and m represents 1 to 4, or a pharmacologically acceptable salt thereof.
    Type: Application
    Filed: July 7, 2016
    Publication date: August 24, 2017
    Applicants: Daiichi Sankyo Company, Limited, Sanford Burnham Prebys Medical Discovery Institute
    Inventors: Shojiro Miyazaki, Yuko Yamamoto, Keisuke Suzuki, Masaharu Inui, Masanori Izumi, Kaori Soma, Anthony Pinkerton, Taeko Shinozaki
  • Patent number: 9719794
    Abstract: A route display method for display on a terminal apparatus comprises: acquiring starting point information indicating a starting point and destination information indicating a destination; generating route information indicating a route from the starting point to the destination, wherein the route information includes a plurality of passing points; extracting captured images corresponding to the plurality of the passing points from a database which stores the captured images in relation to corresponding image capturing locations respectively, wherein each of the image capturing locations is within a range from the each of the plurality of the passing points; and displaying the extracted captured images in association with a map image sequentially in an order from a first captured image corresponding to a first passing point closest to the starting point to a second captured image corresponding to a second passing point closest to the destination.
    Type: Grant
    Filed: September 3, 2015
    Date of Patent: August 1, 2017
    Assignee: PANASONIC INTELLECTUAL PROPERTY CORPORATION OF AMERICA
    Inventors: Toshihisa Nakano, Tohru Wakabayashi, Yuko Yamamoto, Masahiro Ito, Kimio Minami, Kazuo Okamura
  • Publication number: 20170210755
    Abstract: The present invention relates to a compound or a pharmacologically acceptable salt thereof having excellent tissue non-specific alkaline phosphatase inhibitory activity. The present invention provides a compound represented by the formula (I): wherein R1 represents a hydrogen atom, an optionally substituted C1-6 alkyl group, or the like, R2 and R3 are the same or different and each represent a hydrogen atom, an optionally substituted C1-6 alkyl group, or the like, R4 and R5 are the same or different and each represent a hydrogen atom, an optionally substituted C1-6 alkyl group, or the like, R6 represents a hydrogen atom or the like, each R7 may be the same or different and may each represent an optionally substituted C1-6 alkoxy group or the like, X represents —CH?, —C(—R7)?, or —N?, and m represents 1 to 4, or a pharmacologically acceptable salt thereof.
    Type: Application
    Filed: April 6, 2017
    Publication date: July 27, 2017
    Applicants: Daiichi Sankyo Company, Limited, Sanford Burnham Prebys Medical Discovery Institute
    Inventors: Shojiro Miyazaki, Yuko Yamamoto, Keisuki Suzuki, Masaharu Inui, Masanori Izumi, Kaori Soma, Anthony Pinkerton, Taeko Shinozaki
  • Publication number: 20170202154
    Abstract: A plant cultivation method is provided and includes grasping tide-generating force (e.g., relative gravity acceleration), and controlling plant growth conditions (e.g., lighting condition) according to the variation in the tide-generating force. A plant cultivation device is provided and has a growing space for cultivating a plant and includes a grasper for grasping a tide-generating force, and a growth conditions controller for controlling a plant growth conditions in the growing space according to the variation in the tide-generating force.
    Type: Application
    Filed: August 27, 2015
    Publication date: July 20, 2017
    Applicant: TOYOTA BOSHOKU KABUSHIKI KAISHA
    Inventor: Yuko YAMAMOTO
  • Publication number: 20170207157
    Abstract: A method for manufacturing a semiconductor package includes: forming an insulating layer on a support plate; forming a via in the insulating layer; locating a semiconductor device on the insulating layer such that an electrode of the semiconductor device is on the via; removing the support plate; forming a seed layer on a surface of the insulating layer opposite to the semiconductor device, in the via, and on a surface of the electrode of the semiconductor device; and forming a metal layer in the via.
    Type: Application
    Filed: December 12, 2016
    Publication date: July 20, 2017
    Inventors: Kiyoaki HASHIMOTO, Yuko YAMAMOTO
  • Publication number: 20170129253
    Abstract: A printing apparatus including: a first nozzle group including a first and third nozzles which ejects a first liquid; and a second nozzle group including a second nozzle which ejects a second liquid, in which, when an ejection state of the liquid ejected from the one nozzle which belongs to the first nozzle group is abnormal, complementation is performed using complementation modes of a first complementation mode that increases the amount of a liquid to be ejected from the first nozzle instead of allowing the one nozzle to eject the liquid, a second complementation mode that increases the amount of the liquid to be ejected from the second nozzle instead of allowing the one nozzle to eject the liquid, and a third complementation mode that increases the amount of the liquid to be ejected from the third nozzle instead of allowing the liquid to be ejected from the one nozzle.
    Type: Application
    Filed: January 13, 2017
    Publication date: May 11, 2017
    Inventors: Akito SATO, Yuko YAMAMOTO, Yuichi YONEYAMA
  • Publication number: 20170107482
    Abstract: The present invention is a method for controlling a regeneration speed of an animal cell that includes a step of grasping tide-generating force and a step of giving a physical stimulus or chemical stimulus to the animal cell according to the variation in the tide-generating force.
    Type: Application
    Filed: September 22, 2016
    Publication date: April 20, 2017
    Applicant: TOYOTA BOSHOKU KABUSHIKI KAISHA
    Inventor: Yuko YAMAMOTO
  • Patent number: 9579887
    Abstract: A printing apparatus including: a first nozzle group including a first and third nozzles which ejects a first liquid; and a second nozzle group including a second nozzle which ejects a second liquid, in which, when an ejection state of the liquid ejected from the one nozzle which belongs to the first nozzle group is abnormal, complementation is performed using complementation modes of a first complementation mode that increases the amount of a liquid to be ejected from the first nozzle instead of allowing the one nozzle to eject the liquid, a second complementation mode that increases the amount of the liquid to be ejected from the second nozzle instead of allowing the one nozzle to eject the liquid, and a third complementation mode that increases the amount of the liquid to be ejected from the third nozzle instead of allowing the liquid to be ejected from the one nozzle.
    Type: Grant
    Filed: June 25, 2015
    Date of Patent: February 28, 2017
    Assignee: Seiko Epson Corporation
    Inventors: Akito Sato, Yuko Yamamoto, Yuichi Yoneyama
  • Patent number: 9393780
    Abstract: A liquid ejecting apparatus including: a first nozzle group including first nozzles which eject a liquid with a first color absorbing light having a predetermined wavelength, a second nozzle group including second nozzles which eject a liquid with a second color absorbing light having a predetermined wavelength, and Q (Q is a natural number satisfying “2?Q”) nozzle groups including nozzles which eject a liquid other than the liquid having the first color and the liquid having the second color; the first nozzle group is provided in a first area, the second nozzle group is provided in a second area, and the Q nozzle groups are not provided between the first area and the second area but provided on the upstream side or the downstream side of the first area and the second area.
    Type: Grant
    Filed: June 25, 2015
    Date of Patent: July 19, 2016
    Assignee: Seiko Epson Corporation
    Inventors: Akito Sato, Yuko Yamamoto, Yuichi Yoneyama
  • Publication number: 20160069703
    Abstract: A route display method for display on a terminal apparatus comprises: acquiring starting point information indicating a starting point and destination information indicating a destination; generating route information indicating a route from the starting point to the destination, wherein the route information includes a plurality of passing points; extracting captured images corresponding to the plurality of the passing points from a database which stores the captured images in relation to corresponding image capturing locations respectively, wherein each of the image capturing locations is within a range from the each of the plurality of the passing points; and displaying the extracted captured images in association with a map image sequentially in an order from a first captured image corresponding to a first passing point closest to the starting point to a second captured image corresponding to a second passing point closest to the destination.
    Type: Application
    Filed: September 3, 2015
    Publication date: March 10, 2016
    Inventors: TOSHIHISA NAKANO, TOHRU WAKABAYASHI, YUKO YAMAMOTO, MASAHIRO ITO, KIMIO MINAMI, KAZUO OKAMURA